The primary effectiveness endpoint was the proportion of patients who maintained pain control [ change from baseline in mean pain intensity ( 11-point numerical rating scale ) less than +1.5 for 3 consecutive days and no more than two doses of rescue medication per day for 3 consecutive days ) during the first week of open-label treatment .